Mark Bethea Mills Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 7905 S Fall Creek Rd, Wilson, WY 83014 Phone: 307-733-9098 |
Rachel Mackey, PPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7905 S Fall Creek Rd, Wilson, WY 83014 Phone: 307-733-9098 Fax: 307-733-7672 |
Peter Moffatt, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 7905 South Fall Creek Road, Wilson, WY 83014 Phone: 307-733-9098 Fax: 307-733-7672 |
Richard Lundeen, CMHW Counselor Medicare: Not Enrolled in Medicare Practice Location: 7905 Fall Creek Rd., Wilson, WY 83014 Phone: 307-733-9098 Fax: 307-733-7672 |
News Archive
Have you ever found yourself struggling to get your order taken at a crowded bar or lunch counter, only to walk away in disgust as more aggressive customers elbow their way to the front? It turns out that flies do much the same thing, according to biologists from the California Institute of Technology (Caltech).
In the largest published study of its kind, with 1,100 patient cases reviewed, a minimally invasive surgical procedure for lung cancer has been shown to be as effective as open surgery with a low risk of complications and high survival rates when performed by experienced thoracic surgeons.
Phillip Robinson has gone from 10 cigarettes a day to one or two every other day after enrolling in a smoking cessation clinical trial launched by researchers at The University of Texas Health Science Center at Houston
Researchers from the Japan Advanced Institute of Science and Technology (JAIST) and Ishikawa Prefectural University, Japan, recently attempted to synthesize the ORF8 protein with the help of a chemical-inducible protein production system using tobacco BY-2 cells. This study has been published demonstrated in the preprint server, bioRxiv.
Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia and chronic myeloid leukemia, and how a new gene target functions for several myeloid malignancies.
› Verified 8 days ago